α,β-cyclic-β-benzamido hydroxamic acids:: Novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-α converting enzyme (TACE)

被引：35

作者：

Ott, Gregory R. ^{[1
]}

Asakawa, Naoyuki ^{[1
]}

Lu, Zhonghui ^{[1
]}

Liu, Rui-Qin ^{[1
]}

Covington, Maryanne B. ^{[1
]}

Vaddi, Krishna ^{[1
]}

Qian, Mingxin ^{[1
]}

Newton, Robert C. ^{[1
]}

Christ, David D. ^{[1
]}

Traskos, James M. ^{[1
]}

James, Carl P. Decicco ^{[1
]}

机构：

[1] Bristol Myers Squibb Res & Dev, Dept Discovery Chem & Discovery Biol, Princeton, NJ 08543 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2008年 / 18卷 / 02期

关键词：

TNF-alpha; tumor necrosis factor-alpha converting enzyme; TACE; matrix metalloproteinase; MMP; beta-amino acid;

D O I：

10.1016/j.bmcl.2007.11.059

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Selective inhibitors of TNF-alpha Converting Enzyme (TACE) based on (1R,2S)-cyclopentyl, (3S,4S)-pyrrolidinyl, and (3R,4S)-tetrahydrofuranyl beta-benzamido hydroxamic acids have been synthesized and evaluated. This study has led to the discovery of novel inhibitors whose profiles include activity against TACE in an enzyme assay, potency in the suppression of LPS-stimulated TNF-alpha in human whole blood, selectivity against a panel of MMPs and oral bioavailability. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：694 / 699

页数：6

共 50 条

[1] Design, synthesis and evaluation of β-benzamido hydroxamic acid inhibitors of TNF-α converting enzyme (TACE).
Ott, GR
Lu, ZH
Asakawa, N
Covington, MB
Qian, MX
Liu, RQ
Newton, RC
Christ, DD
Decicco, CP
Duan, JJW
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U966 - U966
[2] α,β-Cyclic-β-benzamido hydroxamic acids:: Novel oxaspiro[4.4] nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-α converting enzyme (TACE)
Ott, Gregory R.
Asakawa, Naoyuki
Liu, Rui-Qin
Covington, Maryanne B.
Qian, Mingxin
Vaddi, Krishna
Newton, Robert C.
Trzaskos, James M.
Christ, David D.
Galya, Laurine
Scholz, Thomas
Marshall, Will
Duan, James J. -W.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (04) : 1288 - 1292
[3] Chromen-based TNF-α converting enzyme (TACE) inhibitors:: Design, synthesis, and biological evaluation
Chun, Kwangwoo
Park, Song-Kyu
Kim, Hwan Mook
Choi, Yongseok
Kim, Myung-Hwa
Park, Chun-Ho
Joe, Bo-Young
Chun, Tae Gyu
Choi, Hyun-Moo
Lee, Hee-Yoon
Hong, Sung Hee
Kim, Myung Sook
Nam, Ky-Youb
Han, Gyoonhee
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (01) : 530 - 535
[4] Discovery of β-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitors
Duan, James J. -W.
Chen, Lihua
Lu, Zhonghui
Xue, Chu-Biao
Liu, Rui-Qin
Covington, Maryanne B.
Qian, Mingxin
Wasserman, Zelda R.
Vaddi, Krishna
Christ, David D.
Trzaskos, James M.
Newton, Robert C.
Decicco, Carl P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (01) : 241 - 246
[5] Synthesis and biological activity of selective pipecolic acid-based TNF-α converting enzyme (TACE) inhibitors
Letavic, MA
Axt, MZ
Barberia, JT
Carty, TJ
Danley, DE
Geoghegan, KF
Halim, NS
Hoth, LR
Kamath, AV
Laird, ER
Lopresti-Morrow, LL
McClure, KF
Mitchell, PG
Natarajan, V
Noe, MC
Pandit, J
Reeves, L
Schulte, GK
Snow, SL
Sweeney, FJ
Tan, DH
Yu, CH
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (10) : 1387 - 1390
[6] The discovery of novel tartrate-based TNF-α converting enzyme (TACE) inhibitors
Rosner, Kristin E.
Guo, Zhuyan
Orth, Peter
Shipps, Gerald W., Jr.
Belanger, David B.
Chan, Tin Yau
Curran, Patrick J.
Dai, Chaoyang
Deng, Yongqi
Girijavallabhan, Vinay M.
Hong, Liwu
Lavey, Brian J.
Lee, Joe F.
Li, Dansu
Liu, Zhidan
Popovici-Muller, Janeta
Ting, Pauline C.
Vaccaro, Henry
Wang, Li
Wang, Tong
Yu, Wensheng
Zhou, Guowei
Niu, Xiaoda
Sun, Jing
Kozlowski, Joseph A.
Lundell, Daniel J.
Madison, Vincent
McKittrick, Brian
Piwinski, John J.
Shih, Neng -Yang
Siddiqui, M. Arshad
Strickland, Corey O.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 1189 - 1193
[7] Novel TNF-α converting enzyme (TACE) inhibitors as potential treatment for inflammatory diseases
Girijavallabhan, Vinay M.
Chen, Lei
Dai, Chaoyang
Feltz, Robert J.
Firmansjah, Luke
Li, Dansu
Kim, Seong Heon
Kozlowski, Joseph A.
Lavey, Brian J.
Kosinski, Aneta
Piwinski, John J.
Popovici-Muller, Janeta
Rizvi, Razia
Rosner, Kristin E.
Shankar, Banderpalle B.
Shih, Neng-Yang
Siddiqui, M. Arshad
Tong, Ling
Wong, Michael K. C.
Yang, De-yi
Yang, Liping
Yu, Wensheng
Zhou, Guowei
Guo, Zhuyan
Orth, Peter
Madison, Vincent
Bian, Hong
Lundell, Daniel
Niu, Xiaoda
Shah, Himanshu
Sun, Jing
Umland, Shelby
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7283 - 7287
[8] Synthesis of piperidine phenyl sulfone hydroxamates as TACE (TNF-α converting enzyme) inhibitors
Park, K
Levin, JI
Aplasca, A
Du, ML
Lovering, FE
Condon, JS
Zhang, YH
Sun, LH
Zhu, Y
Xu, WX
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U151 - U152
[9] Design, synthesis and evaluation of β-amino hydroxamic acids as selective tumor necrosis factor-α converting enzyme inhibitors.
Duan, JJW
Ott, GR
King, BW
Maduskuie, TP
Xue, CB
Chen, LH
Lu, ZH
Gilmore, JL
Asakawa, N
Mercer, SE
Xu, MZ
Harris, CM
Wasserman, ZR
Liu, RQ
Covington, MB
Qian, MX
Vaddi, KG
Christ, DD
Hardman, KD
Ribadeneira, MD
Newton, RC
Trzaskos, JM
Decicco, CP
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U38 - U38
[10] Synthesis and activity of tryptophan sulfonamide derivatives as novel non-hydroxamate TNF-α converting enzyme (TACE) inhibitors
Park, Kaapjoo
Gopalsamy, Ariamala
Aplasca, Alexis
Ellingboe, John W.
Xu, Weixin
Zhang, Yuhua
Levin, Jeremy I.
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (11) : 3857 - 3865

← 1 2 3 4 5 →